Seven Eight Capital LP Purchases Shares of 41,556 CymaBay Therapeutics, Inc. (NASDAQ:CBAY)

Seven Eight Capital LP purchased a new stake in shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 41,556 shares of the biopharmaceutical company’s stock, valued at approximately $620,000. A number of other […]

Related Keywords

Janet Dorling , Raymond James , Piper Sandler , Sujal Shah , Cymabay Therapeutics Inc , Glenmede Trust Co , Nasdaq , Exchange Commission , Group Plc , Alps Advisors Inc , Affinity Asset Advisors , Seven Eight Capital , Cymabay Therapeutics , Free Report , General Group Plc , Asset Advisors , Director Janet Dorling , Bay Therapeutics , Get Free Report , Visit Holdingschannel , Cymabay Therapeutics Daily ,